Christoph Haussmann

Title: Christoph Haussmann: Innovator in Influenza Vaccine Development

Introduction

Christoph Haussmann is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of vaccine development, particularly in the preparation of influenza virus vaccine antigens. With a total of 2 patents to his name, Haussmann's work has the potential to enhance public health through improved vaccination methods.

Latest Patents

Haussmann's latest patents focus on the preparation of influenza virus vaccine antigens. These patents disclose a number of improvements for preparing vaccine antigens from disintegrated influenza viruses. A splitting step can be followed by detergent exchange, which is crucial for the effective preparation of these antigens. Additionally, the splitting process can occur in the presence of a buffer with a higher ionic strength and/or in the presence of phosphate buffer, further optimizing the vaccine preparation process.

Career Highlights

Throughout his career, Christoph Haussmann has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Seqirus UK Limited and Novartis AG, where he has contributed to advancements in vaccine technology. His expertise in this area has positioned him as a valuable asset in the field of immunology.

Collaborations

Haussmann has collaborated with several professionals in his field, including Frank Hauschild and Bjorn Jobst. These collaborations have likely enriched his research and contributed to the successful development of his patents.

Conclusion

In summary, Christoph Haussmann is a distinguished inventor whose work in influenza vaccine development has the potential to make a significant impact on public health. His innovative approaches and collaborations highlight his commitment to advancing vaccine technology.